A CASE OF RECURRENT TUBERCULOSIS -LAVANYA DR. S. BALASUBRAMANIAN S UNIT SR. CONSULTANT KKCTH

Similar documents
Feature Articles. Mendelian Susceptibility to Mycobacterial Infection in Childhood: Genetic Defects of IL-12-dependent IFNγ-mediated Immunity

Fever in Lupus. 21 st April 2014

Communicable Disease Control Manual Chapter 4: Tuberculosis

NTM Lecture Series. Challenging Cases: Part 1. Property of Presenter

AIDS. 1) Mycobacterium avium MRI (T2WI) HTLV-1 AIDS. Key words: Mycobacterium avium AIDS. Mycobacterium. complex MAC M. avium M.

HIDDEN IN PLAIN SITE:

Didactic Series. Latent TB Infection in HIV Infection

Tuberculosis Tools: A Clinical Update

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Mycobacterial Infections and HIV

CHAPTER 3: DEFINITION OF TERMS

BCG OSTEITIS. B. Varbanova 1, V. Vasileva 1, P. Minchev 2, R. Nedeva 1 and E. Dyankov 1 BCG. . Bacille-Calmette Guerin (BCG) BCG.

Clinical Immunodeficiency. Dr Claire Bethune Consultant Immunologist

Diagnosis of tuberculosis in children

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Research in Tuberculosis: Translation into Practice

Osteomyelitis Caused by Bacille Calmette-Gu (BCG) Vaccination: 2 Cases

Didactic Series. Latent TB Infection in HIV Infection

Chapter 13: Cytokines

PITFALLS IN THE DIAGNOSIS OF SKELETAL TUBERCULOSIS IN CHILDREN

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

ESCMID Online Lecture Library. by author

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Primary paediatric TH1 immunodeficiency with BCG osis

Cerebral Toxoplasmosis in HIV-Infected Patients. Ahmed Saad,MD,FACP

Mendelian susceptibility to mycobacterial disease

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE

NTM Plus Case Studies

Adaptive Immunity to Bacteria. T cell subsets

Index. Note: Page numbers of article titles are in boldface type.

Director, University Health Services. Medical Director

Tuberculosis Past. Jaap T. van Dissel. National Institute for Public Health and the Environment RIVM Bilthoven The Netherlands

Evaluation and Management of the Patient with Latent Tuberculosis Infection (LTBI)

Technical Bulletin No. 172

Identifying TB co-infection : new approaches?

CDC IMMIGRATION REQUIREMENTS:

NTM Lecture Series. Challenging Cases: Part 2. Property of Presenter

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

Fever of unknown origin

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Profile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital

Enlarging TB Lymph Node Improving or Deteriorating? History. History. Physical examination. Distribution of lymph nodes

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist

Re-emerging infections: Syphilis & Tuberculosis

AIDS at 25. Epidemiology and Clinical Management MID 37

Update on TB Vaccines. Mark Hatherill South African TB Vaccine Initiative (SATVI) University of Cape Town

Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018

TB Clinical Guidelines: Revision Highlights March 2014

Diagnosis and Medical Management of Latent TB Infection

Tuberculosis Intensive

Case Study: TB-HIV co-infection

Dr Francis Ogaro MTRH ELDORET

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Monitoring tuberculosis progression using MRI and stereology

TB Update: March 2012

A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire.

PNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

Dr Marie Bruyneel and Deborah Konopnicki. BVIKM/SBMIC November 8th, 2012

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37

TUBERCULOUS OSTEOMYELITIS OF PATELLA: A CASE REPORT Babu B. Hundekar 1

In our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

TB Intensive San Antonio, Texas December 1-3, 2010

RAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

PROTOCOLS. Severe combined immunodeficiency. Principal investigators. Background. Dr. Louise Pelletier* Dr. Rosemarie Ramsingh

Complication of Bacillus Calmette-Guerin (BCG) Vaccine in HIV-infected Children

Diagnostic Value of Elisa Serological Tests in Childhood Tuberculosis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

TUBERCULOSIS. Pathogenesis and Transmission

Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!!

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Interferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis

Blood Cancer: Chronic Myelogenous Leukaemia

Peggy Leslie-Smith, RN

Bone Marrow Transplantation in X-linked T-B+NK- SCID patient with Pneumocystis carinii pneumonia

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

Summary of Immunization Options

Charcot Arthropathy of the Foot & Ankle. MTAPA Annual Meeting June 2018 Emily Harnden, MD

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

The Origin of Swine Flu

Self-Study Modules on Tuberculosis

Tuberculosis Intensive

Tuberculosis Pathogenesis

LATENT TUBERCULOSIS. Robert F. Tyree, MD

Agammaglobulinemia. Vilnius University Children s s Hospital Pediatric Center, R.Duobiene

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

MANAGEMENT OF TUBERCULOSIS IN NEONATES AND YOUNG INFANTS

Management of Drug-resistant Tuberculosis (DR-TB)

Nucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services

Transcription:

A CASE OF RECURRENT TUBERCULOSIS -LAVANYA DR. S. BALASUBRAMANIAN S UNIT SR. CONSULTANT KKCTH

PRESENTING COMPLAINTS 8 year old boy 3 o consanguineous marriage low grade fever and swelling left parotid area - 15 days poor weight gain --- 2-3 years.

PAST HISTORY @ 2/12, (at Trichy) Head injury with seizures CT - bilateral subdural hematoma. oral phenytoin. BCG adenitis + and ATT (HR) initiated.

@7/12, (at KKCTH) wheeze assoc LRI, anemia and hepatosplenomegaly with BCG adenitis. +ve CMV IgM. Symptomatic treatment given and ATT continued (for 9 months)

@ 6 yrs of age, (at KKCTH) fever x 1 month pain - right knee and thigh

Investigations TC- (18,500 p-78%) CRP (143.6) ESR (100/132) ASO (380) Mantoux negative Aspirate from the right hip: LDH(3640), Proteins (5.9) ve gram stain and AFB.

Persistent fever Further work up : RA factor - negative ANA - negative CT PNS lytic lesion in mandible Chest X-ray - osteitic changes in the 3rd, 4th and 5th ribs.

HIV ELISA ve NBT test ve BONE SCAN - multifocal bone involvement BONE BIOPSY - mycobacterial osteomyelitis

Treated with 4 drug regime of ATT ( HRZE ), given for 3 months HR initiated for continuation. Culture- Mycobacterium.TB resistant to INH. RE continued for 8 months.

This was when he presented to us

EXAMINATION He was under nourished, pale. right parotid swelling hepatosplenomegaly non healing ulcer over the biopsy site (symphysis pubis).

INVESTIGATIONS TC- (22,300 P65,L30) ESR (110/133) CRP(182), Haemoglobin(9). Chest X-ray, RFT & urine analysis normal.

Immunoglobulin-N (IgG-2460, IgM-209, IgA-577, IgE-8) Repeat NBT test ve. ANA, ANCA -ve. Flowcytometry N. TB Quantiferon Gold ve.

GJ AFB x 3 negative Bone marrow - reactive. Whole body MRI s/o foci of TB (right cerebellum, right upper ribs, right lung, right tensor fasciaelata & both iliac bones) CSF analysis (TC-60, L95 P5 ; Sug63 Pro52 Cl 114) CSF Culture ve AFB

THE STORY SO FAR BCG adenitis Multifocal osteomyelitis Cold abscess over parotid with multiple bony foci and CNS involvement (responding to treatment) WHY IS HE RELAPSING???

POSSIBILITIES Drug resistance only H resistance, responds to treatment Paradoxical response no worsening during treatment, relapses Immunodeficiency probably abnormal host response

Any ideas from the post graduates????

MY DEAR WATSON IS IT INTRINSIC IMPAIRMENT OF IFNγ PATHWAY RESPONSE 1.Interferon gamma receptor ligandbinding chain (IFN gamma R1), 2.Interferon gamma receptor signalling chain (IFN gamma R2), 3.Interleukin 12 p40 subunit (IL-12 p40), 4.Interleukin 12 receptor beta 1 chain (IL-12R beta 1) genes

CALL FOR HELP Mail to Dr. Casanova in France (nearly 100 papers on IFN gamma pathway abnormalities) Blood specimens sent as suggested for further analysis.

7 drug regimen of ATT initiated. Ofloxacin (15 mg/kg), clarithromycin (10 mg/kg), HRZES for 2 months HRE continuation initiated. Recurrence of parotid abscess. I&D done and sample sent for culture. HRZE+ Oflox given for 2 months

He was reviewed after 2 months: Culture : Mycobacterium avium intracellulare. TREATMENT: Clarithromycin(25mg/kg) Ciprofloxacin(20mg/kg) HRE

On Sat, Nov 14, 2009 at 8:56 PM, Jacinta BUSTAMANTE Dear Dr Balasubramanian, Some time ago, you sent in our lab the blood samples from your patient Mohammed Thaseem Anwar. He suffered disseminated mycobacterial infections. (BCG disease versus tuberculosis disease). The test in the lab show low response of activation BCG+IFNg in term of IL12 production and he had also the IFNg detected in plasma. We found a new variation in IFNGR1 gene located in exon 2. We need study your patient and we need characterize the defect. At the moment we don't know if he suffer a complete or partial defect and the treatment depend of the disease. Could you have to contact your patient and send us an other blood samples? Thanks you very much for help, Sincerely, Jacinta Jacinta Cecilia Bustamante MD, PhD Laboratoire de Génétique Humaine des Maladies Infectieuses INSERM - U550 Faculté de Médecine Necker 156 rue de Vaugirard 75015 Paris, FRANCE, UE Téléphone 33 1 40 61 53 38 FAX 33 1 40 61 56 88 E-mail jacinta.bustamante@inserm.fr web site http://www.hgid.net

DIAGNOSIS new variation in IFNGR1 gene located in exon 2. Gamma interferon RECEPTOR defect

Gamma interferon receptor defect

IFN-gamma receptor ligand-binding chain (IFNgammaR1) deficiency life-threatening AR immune disorder. deleterious mutations Present with disseminated TB or BCG and NTM infection.

Intrinsic impairment in IFN-gamma pathway, particular to mycobacteria. (not susceptible to any other agents) inhibit activation of macrophages up regulation of TNFα is impaired intracellular pathogens +++.

Affected children die of mycobacterial infection. Mutations - premature stop codon - precluding cell surface expression of the receptors. Treatment is long term ATT.

complete IFNgammaR1 deficiencyfatal lepromatoid BCG infection and disseminated NTM infection partial IFNgammaR1 deficiency - curable tuberculoid BCG infection and clinical tuberculosis.

Only 2 case reports are published. Further work up in him is pending. Waiting for him to come for review.

TAKE HOME MESSAGE TRY, TRY, TRY UNTIL YOU SUCCEED!!! It is imperative to keep searching for a cause in children with recurrent complaints.

References 1.Disseminated Mycobacterium tuberculosis infection due to interferon γ deficiency. Response to replacement therapy Author Affiliations Correspondence to: Dr Suranjith Luke Seneviratne Department of Clinical Immunology, Manchester Royal Infirmary Manchester M13 9WL, UK;suran200@yahoo.co.uk 2. Extensively drug resistant tuberculosis in a 7-year-old child with interferon-{gamma} and interleukin-12 deficiency K. Kulkarni,M. Singh, P. Soneja, J. Mathew, R. K. Marwaha BMJ Case Reports 2009;2009:bcr0620080293

3.Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin- 12Rbeta1-deficient Slovakian children. Ulrichs T, Fieschi C, Nevicka E, Hahn H, Brezina M, Kaufmann SH, Casanova JL, Frecerova K.

THANK YOU